Pricing Log in Create free account

IDEAYA Biosciences, Inc. (IDYA) vs Viridian Therapeutics, Inc. (VRDN)

IDEAYA Biosciences, Inc. and Viridian Therapeutics, Inc. are both Biotechnology companies. IDEAYA Biosciences, Inc. and Viridian Therapeutics, Inc. are of similar size ($3.2B and $3.0B). Viridian Therapeutics, Inc. grew revenue faster over the last twelve months: −62.8% against −83.6%. IDEAYA Biosciences, Inc. has the higher net margin (−1,149.6% vs −1,724.1%) and the lower return on invested capital (−114.2% vs 0.00%). Across the 16 metrics below, IDEAYA Biosciences, Inc. leads on 9 and Viridian Therapeutics, Inc. on 7.

Valuation

Metric IDYA VRDN Biotechnology median
P/E n/m n/m 10.26
P/S 86.70 117.81 9.18
P/B 2.90 5.49 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales 63.75 91.03 8.98
Earnings yield (14.60%) (11.73%) (34.89%)
Free cash flow yield (11.04%) (11.08%) (24.52%)

Profitability

Metric IDYA VRDN Biotechnology median
Gross margin 100.00% 100.00% 65.16%
Operating margin (1,267.38%) (1,781.38%) 0.00%
Net margin (1,149.62%) (1,724.06%) 0.00%
Free cash flow margin (957.43%) (1,305.42%) 0.00%
Return on equity (38.46%) 0.00% (50.12%)
Return on assets (34.98%) (56.49%) (45.60%)
Return on invested capital (114.15%) 0.00% 0.00%

Growth

Metric IDYA VRDN Biotechnology median
Revenue growth (TTM) (83.64%) (62.83%) 6.26%
EPS growth (last fiscal year) 61.90% (8.14%) 29.88%
Revenue growth, 5-year CAGR 62.11% 132.18% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IDYA VRDN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 9.04 14.46 4.89
Net debt to EBITDA 3.88 2.23 1.01

Dividend

Metric IDYA VRDN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric IDYA VRDN Biotechnology median
Market cap 2.96b 3.23b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack